X
GO

Dr. Michele Carbone's Scientific Publications

Proceedings of the National Academy of Sciences of the United States of America

Proceedings of the National Academy of Sciences of the United States of America

High-density array-CGH with targeted NGS unmask multiple noncontiguous minute deletions on chromosome 3p21 in mesothelioma

We found that gene mutations/deletions are frequent in mesothelioma and occur through a variety of DNA alterations. We identified genes implicated in malignant mesothelioma: SETD2, SMARCC1, PBRM1.
0 Comments
View IASLC CME Webinar Powerpoint Presented by Drs. Michele Carbone & Harvey Pass

View IASLC CME Webinar Powerpoint Presented by Drs. Michele Carbone & Harvey Pass

Mesothelioma: Causes, Prevention, Screening and Early Detection

The International Association for the Study of Lung Cancer (IASLC) sponsored a live 60-minute CME webinar on November 15, 2016  featuring Dr. Michele Carbone, MD, PhD and Dr. Harvey I. Pass, MD .  The webinar describes clinical research efforts focusing on how mesothelioma prevention and intervention at earlier stages of the disease process may improve the management of mesothelioma.

 

0 Comments

Investigating palygorskite’s role in the development of mesothelioma in southern Nevada

Insights into fiber-induced carcinogenicity

Similar to asbestos fibers, nonregulated mineral fibers can cause malignant mesothelioma (MM). Recently, increased proportions of women and young individuals with MM were identified in southern Nevada.
0 Comments
Environmental risk of mesothelioma in the United States

Environmental risk of mesothelioma in the United States

An emerging concern—epidemiological issues

Despite predictions of decline in mesothelioma following the ban of asbestos in most industrial countries, the incidence is still increasing globally, particularly in women.

 

0 Comments
Oncogene - Meeting Report:

Oncogene - Meeting Report:

Association of SV40 with human tumors

Meeting Report:   Studies conducted by the various investigators were presented addressing the association of SV40 with human mesothelioma. Joseph Testa (Fox Chase Cancer Center, Philadelphia, PA, USA) reported the conclusions of a multi-laboratory study he had directed following the recommendation of the 1997 NIH conference (see Carbone et al. (1997b) for meeting review of 1997 NIH conference) and upon the request of the International Mesothelioma Interest Group (IMIG).

 

Authors: George Klein, Amy Powers and Carlo Croce

0 Comments
RSS
123456